Canterbury DHB


Prevention of Infection

Many blood diseases and their treatments increase the risk of infection. The exact infection risk relates to a number of factors; most importantly, the severity and duration of neutropenia (e.g. AML and ALL induction treatments), and the degree of immunosuppression (ALL and intensive myeloma treatments, all allografts, GvHD). The measures to try and counteract this increased risk of infection will therefore vary according to the clinical situation. The following sections indicate the general principles and practice that are recommended.

In This Section

Quick look infection prevention and control isolation requirements in B6

Protective Isolation

B6 Maintenance

Preventing Infections

Oral Hygiene


Perianal Care

Prevention of Diarrhoea

Summary of Antimicrobial Prophylaxis for SCT

Vaccination Policy in Haematology Patients

About this Canterbury DHB document (9468):

Document Owner:

Andrew Butler (see Who's Who)

Last Reviewed:

May 2021

Next Review:

May 2023


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 9468